Morning Movers 1/27: CV Therapeutics (CVTX) Surges On Takeover Bid, Verizon (VZ) Lower After Results - Street Insider

Sign Up | Log In | What is SocialPicks?

Morning Movers 1/27: CV Therapeutics (CVTX) Surges On Takeover Bid, Verizon (VZ) Lower After Results
Jan 27, 2009 02:56 PM UTC

Street Insider

Return	Risk
+0.33%	MID

Tracked Blogger

Profile & Performance

Subscribe to author

Symbol	Sentiment	Start	Return	Closed
CVTX	n/a
VZ	n/a

Via StreetInsider.com News Articles:

StreetInsider.com Morning Movers:

CV Therapeutics, Inc. (Nasdaq: CVTX) 40% HIGHER; Japanese drugmaker Astellas Phama has offered to acquire CV Therapeutics, Inc. (Nasdaq: CVTX) for $16 per share, which is a nice premium to yesterday's $11.35 per share closing. CV Therapeutics rejected the overture.

Phoenix Technologies (Nasdaq: PTEC) 29% LOWER; reports Q4 loss of $0.18, 8 cents below the analyst estimate of ($0.10). Revenue for the quarter was $17.4 million, versus the consensus of $18.75 million.

Zions Bancorp (Nasdaq: ZION) 19% HIGHER; reports Q4 loss of $0.32, 2 cents lower than the analyst estimate of ($0.30).

Netflix (Nasdaq: NFLX) 17%

Read the rest of original post »

Add Comment

Be the first to comment on this story and earn 2 points.

Your Comment

IN THE PRESS

None of the information contained on SocialPicks.com constitutes a recommendation by SocialPicks or its users that any particular security, portfolio of securities, transaction, or investment strategy is suitable for any specific person. SocialPicks is not responsible for the posts, discussions, and recommendations of the users on the Site. SocialPicks does not provide investment advice. You must make your own independent decisions regarding any security, portfolio of securities, transaction, or investment strategy mentioned on the website. SocialPicks' users' past results are not necessarily indicative of future performance. Neither SocialPicks nor any of its users guarantees any specific outcome or profit, and you should be aware of the real risk of loss in following any strategy or investments discussed on the website. You understand and agree that you use the Site and Services at your own discretion and risk and that you will be solely responsible for any damages that arise from such use. Before acting on any information contained on the website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.